| Defining the clinical course of multiple sclerosis: the 2013 revisions FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ... Neurology 83 (3), 278-286, 2014 | 4068 | 2014 |
| The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease S Youssef, O Stüve, JC Patarroyo, PJ Ruiz, JL Radosevich, EM Hur, ... Nature 420 (6911), 78-84, 2002 | 1392 | 2002 |
| Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018 | 1075 | 2018 |
| MRI characteristics of neuromyelitis optica spectrum disorder: an international update HJ Kim, F Paul, MA Lana-Peixoto, S Tenembaum, N Asgari, J Palace, ... Neurology 84 (11), 1165-1173, 2015 | 662 | 2015 |
| The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review RA Marrie, S Reingold, J Cohen, O Stuve, M Trojano, PS Sorensen, ... Multiple Sclerosis Journal 21 (3), 305-317, 2015 | 628 | 2015 |
| Type II monocytes modulate T cell–mediated central nervous system autoimmune disease MS Weber, T Prod'homme, S Youssef, SE Dunn, CD Rundle, L Lee, ... Nature medicine 13 (8), 935-943, 2007 | 544 | 2007 |
| Interferon beta in the treatment of multiple sclerosis: mechanisms of action V Wee Yong, S Chabot, O Stuve, G Williams Neurology 51 (3), 682-689, 1998 | 519 | 1998 |
| Immune surveillance in multiple sclerosis patients treated with natalizumab O Stüve, CM Marra, KR Jerome, L Cook, PD Cravens, S Cepok, ... Annals of Neurology: Official Journal of the American Neurological …, 2006 | 505 | 2006 |
| Acute disseminated encephalomyelitis: an update T Menge, B Hemmer, S Nessler, H Wiendl, O Neuhaus, HP Hartung, ... Archives of neurology 62 (11), 1673-1680, 2005 | 499 | 2005 |
| A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview RA Marrie, J Cohen, O Stuve, M Trojano, PS Sørensen, S Reingold, ... Multiple Sclerosis Journal 21 (3), 263-281, 2015 | 473 | 2015 |
| Interferon β‐1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase‐9 O Stüve, NP Dooley, JH Uhm, JP Antel, GS Francis, VW Yong, G Williams Annals of Neurology: Official Journal of the American Neurological …, 1996 | 460 | 1996 |
| Treatment of neuromyelitis optica: review and recommendations DJ Kimbrough, K Fujihara, A Jacob, MA Lana-Peixoto, MI Leite, M Levy, ... Multiple sclerosis and related disorders 1 (4), 180-187, 2012 | 352 | 2012 |
| Factors that influence adherence with disease-modifying therapy in MS K Treadaway, G Cutter, A Salter, S Lynch, J Simsarian, J Corboy, ... Journal of neurology 256, 568-576, 2009 | 344 | 2009 |
| Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke DP Hopkins, PA Briss, CJ Ricard, CG Husten, VG Carande-Kulis, ... American journal of preventive medicine 20 (2), 16-66, 2001 | 335 | 2001 |
| Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis R Zivadinov, AT Reder, M Filippi, A Minagar, O Stuve, H Lassmann, ... Neurology 71 (2), 136-144, 2008 | 310 | 2008 |
| Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis O Stüve, CM Marra, A Bar-Or, M Niino, PD Cravens, S Cepok, ... Archives of neurology 63 (10), 1383-1387, 2006 | 307 | 2006 |
| Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study K Selmaj, DKB Li, HP Hartung, B Hemmer, L Kappos, MS Freedman, ... The Lancet Neurology 12 (8), 756-767, 2013 | 287 | 2013 |
| The utility of cerebrospinal fluid analysis in patients with multiple sclerosis M Stangel, S Fredrikson, E Meinl, A Petzold, O Stüve, H Tumani Nature Reviews Neurology 9 (5), 267-276, 2013 | 273 | 2013 |
| The increasing incidence and prevalence of female multiple sclerosis—a critical analysis of potential environmental factors J Sellner, J Kraus, A Awad, R Milo, B Hemmer, O Stüve Autoimmunity reviews 10 (8), 495-502, 2011 | 272 | 2011 |
| Optical coherence tomography in multiple sclerosis E Frohman, F Costello, R Zivadinov, O Stuve, A Conger, H Winslow, ... The Lancet Neurology 5 (10), 853-863, 2006 | 234 | 2006 |
